- Home
- ARBB vs ADAP Comparison
ARBB vs ADAP Comparison
Compare ARBB & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- ADAP
- Stock Information
- Founded
- ARBB 1997
- ADAP 2008
- Country
- ARBB Singapore
- ADAP United Kingdom
- Employees
- ARBB N/A
- ADAP N/A
- Industry
- ARBB EDP Services
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- ADAP Health Care
- Exchange
- ARBB Nasdaq
- ADAP Nasdaq
- Market Cap
- ARBB 18.3M
- ADAP 21.3M
- IPO Year
- ARBB 2023
- ADAP 2015
- Fundamental
- Price
- ARBB $7.41
- ADAP $0.18
- Analyst Decision
- ARBB Strong Buy
- ADAP Hold
- Analyst Count
- ARBB 1
- ADAP 6
- Target Price
- ARBB $20.00
- ADAP $1.02
- AVG Volume (30 Days)
- ARBB 970.5K
- ADAP 139.3M
- Earning Date
- ARBB 11-26-2025
- ADAP 11-12-2025
- Dividend Yield
- ARBB N/A
- ADAP N/A
- EPS Growth
- ARBB N/A
- ADAP N/A
- EPS
- ARBB N/A
- ADAP N/A
- Revenue
- ARBB $24,425,491.00
- ADAP $65,084,999.00
- Revenue This Year
- ARBB N/A
- ADAP N/A
- Revenue Next Year
- ARBB $462.92
- ADAP $24.70
- P/E Ratio
- ARBB N/A
- ADAP N/A
- Revenue Growth
- ARBB N/A
- ADAP N/A
- 52 Week Low
- ARBB $3.62
- ADAP $0.04
- 52 Week High
- ARBB $18.60
- ADAP $0.96
- Technical
- Relative Strength Index (RSI)
- ARBB 54.78
- ADAP 60.70
- Support Level
- ARBB $7.25
- ADAP $0.12
- Resistance Level
- ARBB $8.90
- ADAP $0.16
- Average True Range (ATR)
- ARBB 1.72
- ADAP 0.03
- MACD
- ARBB -0.13
- ADAP 0.00
- Stochastic Oscillator
- ARBB 32.04
- ADAP 37.41
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.